Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04099836
Title Atezolizumab and Bevacizumab in Epidermal Growth Factor Receptor (EGFR) Mutant Non-Small Cell Lung Cancer in Patients With Progressive Disease After Receiving Osimertinib
Recruitment Suspended
Gender both
Phase Phase II
Variant Requirements No
Sponsors Duke University
Indications

lung non-squamous non-small cell carcinoma

Therapies

Atezolizumab + Bevacizumab

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.